NEW YORK (GenomeWeb) – Cancer Genetics today announced it has arranged an in-network provider agreement with Blue Cross Blue Shield of Illinois to offer cancer diagnostic services.

Under the terms of the agreement, BCBS Illinois' network will have access to Cancer Genetics' full range of oncology-focused tests. The insurance plan covers 7.3 million people in the state.

Financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.